Bibliography: library/10665-362227

The reference for library/10665-362227 (who-iris) and any references extracted from it. library · All references.

Export these 127 references: BibTeX · CSL-JSON · RIS · Dublin Core XML · Dublin Core / BIBO JSON-LD

✍ + Add reference (standalone node)

Build a standalone folio-reference/v1 node at references/reference.jsonld from fields or pasted BibTeX / CSL-JSON.



· ✍ Create standalone node on GitHub · Download .jsonld · Download .csl.json ·

127 shown

  1. World Health Organization (2022). WHO implementation tool for pre-exposure prophylaxis (PrEP) of HIV infection: module 13: integrating STI services. World Health Organization.
    10665-362227 · catalogue · link · repository record · ISBN 9789240057425 (electronic version) · source: catalogue/records/10665-362227.dc.json · held: library/10665-362227
    export: BibTeX · RIS · CSL-JSON · DC XML
  2. Guideline on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV. Geneva: World Health Organization; 2015 (https://www.who.int/publications/i/item/9789241509565, accessed 29 July 2022).
    · extracted · link · source: references/10665-362227.sec-035.1.json
  3. Differentiated and simplified pre-exposure prophylaxis for HIV prevention: update to WHO implementation guidance. Technical Brief. Geneva: World Health Organization; 2022 (https://www.who.int/publications/i/item/9789240053694, accessed 29 July 2022).
    · extracted · link · source: references/10665-362227.sec-035.2.json
  4. WHO recommends the dapivirine vaginal ring as a new choice for HIV prevention for women at substantial risk of HIV infection [webpage]. Geneva: World Health Organization; 2022 (https://www.who.int/news/item/26-01-2021-who-recommends-the-dapivirine-vaginal-ring-as-a-new-choice-for-hiv-prevention-for-women-at-substantial-risk-of-hiv-infection, accessed 8 August 2022).
    · extracted · link · source: references/10665-362227.sec-035.3.json
  5. Guidelines on long-acting injectable cabotegravir for HIV prevention. Geneva: World Health Organization; 2022 (https://www.who.int/publications/i/item/9789240054097, accessed 28 July 2022).
    · extracted · link · source: references/10665-362227.sec-035.4.json
  6. Defining sexual health [webpage]. Geneva: World Health Organization; 2022 (https://www.who.int/teams/sexual-and-reproductive-health-and-research/key-areas-of-work/sexual-health/defining-sexual-health, accessed 15 July 2022).
    · extracted · link · source: references/10665-362227.sec-035.5.json
  7. Global progress report on HIV, viral hepatitis and sexually transmitted infections. Geneva: World Health Organization; 2021 (https://apps.who.int/iris/handle/10665/342813, accessed 29 July 2022).
    · extracted · link · source: references/10665-362227.sec-035.6.json
  8. Rowley J, Vander Hoorn S, Korenromp E, Low N, Unemo M, Abu-Raddad LJ et al. Chlamydia, gonorrhoea, trichomoniasis and syphilis: global prevalence and incidence estimates, 2016. Bull World Health Organ. 2019;97(8):548-562P.
    · extracted · source: references/10665-362227.sec-035.7.json
  9. Korenromp EL, Rowley J, Alonso M, Mello MB, Wijesooriya NS, Mahiané SG et al. Global burden of maternal and congenital syphilis and associated adverse birth outcomes-Estimates for 2016 and progress since 2012. PLoS One. 2019;14(2):e0211720. Erratum in: PLoS One. 2019;14(7):e0219613.
    · extracted · source: references/10665-362227.sec-035.8.json
  10. James C, Harfouche M, Welton NJ, Turner KM, Abu-Raddad LJ, Gottlieb SL et al. Herpes simplex virus: global infection prevalence and incidence estimates, 2016. Bull World Health Organ. 2020;98(5):315-329. Epub 2020 Mar 25.
    · extracted · source: references/10665-362227.sec-035.9.json
  11. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209–49.
    · extracted · source: references/10665-362227.sec-035.10.json
  12. Ong JJ, Baggaley RC, Wi TE, Tucker JD, Fu H, Smith MK et al. Global epidemiologic characteristics of sexually transmitted infections among individuals using pre-exposure prophylaxis for the prevention of HIV infection: a systematic review and meta-analysis. JAMA Netw Open. 2019;2(12):e1917134.
    · extracted · source: references/10665-362227.sec-035.11.json
  13. Jin F, Dore GJ, Matthews G, Luhmann N, Macdonald V, Bajis S et al. Prevalence and incidence of hepatitis C virus infection in men who have sex with men: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2021 Jan;6(1):39-56.
    · extracted · source: references/10665-362227.sec-035.12.json
  14. Stewart J, Bukusi E, Celum C, Delany-Moretlwe S, Baeten JM. Sexually transmitted infections among African women: an opportunity for combination sexually transmitted infection/HIV prevention. AIDS. 2020;34(5):651-658.
    · extracted · source: references/10665-362227.sec-035.13.json
  15. Wu MY, Gong HZ, Hu KR, Zheng HY, Wan X, Li J. Effect of syphilis infection on HIV acquisition: a systematic review and meta-analysis. Sex Transm Infect. 2021;97(7):525-533.
    · extracted · source: references/10665-362227.sec-035.14.json
  16. Looker KJ, Welton NJ, Sabin KM, Dalal S, Vickerman P, Turner KM et al. Global and regional estimates of the contribution of herpes simplex virus type 2 infection to HIV incidence: a population attributable fraction analysis using published epidemiological data. Lancet Infect Dis. 2020;20(2):240-9.
    · extracted · source: references/10665-362227.sec-035.15.json
  17. Masha SC, Cools P, Sanders EJ, Vaneechoutte M, Crucitti T. Trichomonas vaginalis and HIV infection acquisition: a systematic review and meta-analysis. Sex Transm Infect. 2019;95:36-42.
    · extracted · source: references/10665-362227.sec-035.16.json
  18. Lazarus E, Otwombe K, Dietrich J, Andrasik MP, Morgan CA, Kublin JG et al. Vaginal practices among women at risk for HIV acquisition in Soweto, South Africa. South Afr J HIV Med. 2019;20(1):866.
    · extracted · source: references/10665-362227.sec-035.17.json
  19. Baggaley RF, White RG, Boily MC. HIV transmission risk through anal intercourse: systematic review, meta-analysis and implications for HIV prevention. Int J Epidemiol. 2010;39(4):1048-63.
    · extracted · source: references/10665-362227.sec-035.18.json
  20. Kabapy AF, Shatat HZ, Abd El-Wahab EW. Attributes of HIV infection over decades (1982-2018): a systematic review and meta-analysis. Transbound Emerg Dis. 2020;67(6):2372-2388.
    · extracted · source: references/10665-362227.sec-035.19.json
  21. Ivanova O, Rai M, Kemigisha E. A systematic review of sexual and reproductive health knowledge, experiences and access to services among refugee, migrant and displaced girls and young women in Africa. Int J Environ Res Public Health. 2018;15(8):1583.
    · extracted · source: references/10665-362227.sec-035.20.json
  22. Confronting discrimination: overcoming HIV-related stigma and discrimination in healthcare settings and beyond. Geneva: Joint United Nations Programme on HIV/AIDS (UNAIDS); 2017 (https://www.unaids.org/sites/default/files/media_asset/confronting-discrimination_en.pdf, accessed 11 August 2022).
    · extracted · link · source: references/10665-362227.sec-035.21.json
  23. Arum C, Fraser H, Artenie AA, Bivegete S, Trickey A, Alary M et al. Homelessness, unstable housing, and risk of HIV and hepatitis C virus acquisition among people who inject drugs: a systematic review and meta-analysis. Lancet Public Health. 2021;6(5):e309-23.
    · extracted · source: references/10665-362227.sec-035.22.json
  24. Lyons CE, Schwartz SR, Murray SM, Shannon K, Diouf D, Mothopeng T et al. The role of sex work laws and stigma in increasing HIV risks among sex workers. Nat Commun. 2020;11:773.
    · extracted · source: references/10665-362227.sec-035.23.json
  25. Li Y, Marshall CM, Rees HC, Nunez A, Ezeanolue EE, Ehiri JE. Intimate partner violence and HIV infection among women: a systematic review and meta-analysis. J Int AIDS Soc. 2014;17(1):18845.
    · extracted · source: references/10665-362227.sec-035.24.json
  26. Birdthistle I, Tanton C, Tomita A, de Graaf K, Schaffnit SB, Tanser F et al. Recent levels and trends in HIV incidence rates among adolescent girls and young women in ten high-prevalence African countries: a systematic review and meta-analysis. Lancet Glob Health. 2019;7(11):e1521-40.
    · extracted · source: references/10665-362227.sec-035.25.json
  27. Garcia PJ, Miranda AE, Gupta S, Garland SM, Escobar ME, Fortenberry JD; International Union Against Sexually Transmitted Infections. The role of sexually transmitted infections (STI) prevention and control programs in reducing gender, sexual and STI-related stigma. EClinicalMedicine. 2021;33:100764.
    · extracted · source: references/10665-362227.sec-035.26.json
  28. Fortenberry JD, McFarlane M, Bleakley A, Bull S, Fishbein M, Grimley DM et al. Relationships of stigma and shame to gonorrhea and HIV screening. Am J Public Health. 2002;92(3):378-381.
    · extracted · source: references/10665-362227.sec-035.27.json
  29. Prevention and control of sexually transmitted infections (STIs) in the era of oral pre-exposure prophylaxis (PrEP) for HIV: technical brief. Geneva: World Health Organization; 2019. (https://www.who.int/publications/i/item/prevention-and-control-of-stis-in-the-era-of-prep-for-hiv, accessed 29 July 2022).
    · extracted · link · source: references/10665-362227.sec-035.28.json
  30. Accelerating the global sexually transmitted infections response: report on the first informal think-tank meeting. Geneva: World Health Organization; 2022 (https://www.who.int/publications/i/item/9789240022591 accessed 8 August 2022).
    · extracted · link · source: references/10665-362227.sec-035.29.json
  31. Framework on integrated, people-centred health services. Geneva: World Health Organization; 2016 (https://apps.who.int/gb/ebwha/pdf_files/WHA69/A69_39-en.pdf, accessed 8 August 2022).
    · extracted · link · source: references/10665-362227.sec-035.30.json
  32. Unemo M, Golparian D, Eyre DW. Antimicrobial resistance in Neisseria gonorrhoeae and treatment of gonorrhea. Methods Mol Biol. 2019;1997:37-58.
    · extracted · source: references/10665-362227.sec-035.31.json
  33. Unemo M, Lahra MM, Escher M, Eremin S, Cole MJ, Galarza P et al. WHO global antimicrobial resistance surveillance (GASP/GLASS) for Neisseria gonorrhoeae 2017-2018: a retrospective observational study. Lancet Microbe 2021; 2: e627–36
    · extracted · source: references/10665-362227.sec-035.32.json
  34. Global Health Sector Strategies on, respectively, HIV, viral hepatitis and sexually transmitted infections for the period 2022-2030 (GHSS). Geneva: World Health Organization; 2022 (https://www.who.int/publications/i/item/9789240053779, accessed 8 August 2022).
    · extracted · link · source: references/10665-362227.sec-035.33.json
  35. Global strategy to accelerate the elimination of cervical cancer as a public health problem. Geneva: World Health Organization; 2020 (https://www.who.int/publications-detail-redirect/9789240014107, accessed 8 August 2022).
    · extracted · link · source: references/10665-362227.sec-035.34.json
  36. Updated recommendations on service delivery for the treatment and care of people living with HIV. Geneva: World Health Organization; 2021 (https://www.who.int/publications/i/item/9789240023581, accessed 8 August 2022).
    · extracted · link · source: references/10665-362227.sec-035.35.json
  37. WHO guideline: recommendations on digital interventions for health system strengthening, Geneva: World Health Organization; 2019 (https://www.who.int/publications/i/item/9789241550505, accessed 8 August 2022).
    · extracted · link · source: references/10665-362227.sec-035.36.json
  38. Policy brief: Virtual interventions in response to HIV, sexually transmitted infections and viral hepatitis. Innovate-Implement-Integrate. Geneva: UNAIDS; 2022 (https://www.unaids.org/sites/default/files/media_asset/policy-brief_virtual-interventions_en.pdf, accessed 8 August 2022).
    · extracted · link · source: references/10665-362227.sec-035.37.json
  39. World Health Organization, President’s Emergency Plan for AIDS Relief, Joint United Nations Programme for HIV/AIDS. Task shifting: rational redistribution of tasks among health workforce teams : global recommendations and guidelines. Geneva: World Health Organization; 2007 (https://apps.who.int/iris/handle/10665/43821, accessed 8 August 2022).
    · extracted · link · source: references/10665-362227.sec-035.38.json
  40. WHO recommendations on self-care interventions. Self-collection of samples for sexually transmitted infections (STIs). Geneva: World Health Organization; 2020 (https://www.who.int/publications/i/item/WHO-SRH-20.10, accessed 8 August 2022).
    · extracted · link · source: references/10665-362227.sec-035.39.json
  41. Guidelines on HIV self-testing and partner notification: supplement to consolidated guidelines on HIV testing services. Geneva: World Health Organization; 2016 (https://apps.who.int/iris/handle/10665/251655, accessed 8 August 2022).
    · extracted · link · source: references/10665-362227.sec-035.40.json
  42. WHO recommends social network-based HIV testing approaches for key populations as part of partner services package. Geneva: World Health Organization; 2019 (https://apps.who.int/iris/handle/10665/329964, accessed 8 August 2022).
    · extracted · link · source: references/10665-362227.sec-035.41.json · held: library/10665-329964
  43. Bristow CC, Larson E, Anderson LJ, Klausner JD. Cost-effectiveness of HIV and syphilis antenatal screening: a modelling study. Sex Transm Infect. 2016;92(5):340-6.
    · extracted · source: references/10665-362227.sec-035.42.json
  44. Rodriguez PJ, Roberts DA, Meisner J, Sharma M, Owiredu MN, Gomez B et al. Cost-effectiveness of dual maternal HIV and syphilis testing strategies in high and low HIV prevalence countries: a modelling study. Lancet Glob Health. 2021;9(1):e61-e71.
    · extracted · source: references/10665-362227.sec-035.43.json
  45. Coomes D, Green D, Barnabas R, Sharma M, Barr-DiChiara M, Jamil M et al. (2022). Cost-effectiveness of implementing HIV and HIV/syphilis dual testing among key populations in Viet Nam: a modeling analysis. (in press, BMJ Open) 10.1101/2022.02.28.22271651.
    · extracted · doi:10.1101/2022.02.28.22271651 · source: references/10665-362227.sec-035.44.json
  46. Needs estimation and costing tool for implementing HIV pre-exposure prophylaxis (PrEP). User guide. Washington (DC): Pan American Health Organization; 2022 (https://iris.paho.org/bitstream/handle/10665.2/55800/PAHOCDEHT220004_eng.pdf?sequence=1&isAllowed=y, accessed 8 August 2022).
    · extracted · link · source: references/10665-362227.sec-035.45.json
  47. Studies: TRaC & the dashboard to decision making process. Washington (DC): Population Services International; 2007 (https://www.psi.org/wp-content/uploads/2007/01/TRaC-Dashboard-Toolkit.pdf, accessed 29 July 2022).
    · extracted · link · source: references/10665-362227.sec-035.46.json
  48. Consolidated guidelines on person-centred HIV strategic information: strengthening routine data for impact. Geneva: World Health Organization; 2022 (https://www.who.int/publications/i/item/9789240055315, accessed 8 August 2022).
    · extracted · link · source: references/10665-362227.sec-035.47.json
  49. WHO Implementation tool for pre-exposure prophylaxis (PrEP) of HIV infection. Module 2: Community educators and advocates. Geneva: World Health Organization; 2017 (https://www.who.int/tools/prep-implementation-tool, accessed 29 July 2022).
    · extracted · link · source: references/10665-362227.sec-035.48.json
  50. What works for generating demand for HIV testing services: policy brief. Geneva: World Health Organization; 2019 (https://apps.who.int/iris/handle/10665/329967, accessed 29 July 2022).
    · extracted · link · source: references/10665-362227.sec-035.49.json
  51. Farmer EK, Koren DE, Cha A, Grossman K, Cates DW. The pharmacist’s expanding role in HIV pre-exposure prophylaxis. AIDS Patient Care STDS. 2019;33(5):207-213.
    · extracted · source: references/10665-362227.sec-035.50.json
  52. Magno L, Soares F, Zucchi EM, Eustorgio M, Grangeiro A, Ferraz D et al. Reaching out to adolescents at high risk of HIV infection in Brazil: Demand creation strategies for PrEP and other HIV combination prevention methods. Arch Sex Behavior. 2022 Jul 25:1-7.
    · extracted · source: references/10665-362227.sec-035.51.json
  53. Luetkemeyer A, Dombrowski J, Cohen S, Donnell D, Grabow C, Brown C et al. Doxycycline post-exposure prophylaxis for STI prevention among MSM and transgender women on HIV PrEP or living with HIV: high efficacy to reduce incident STIs in a randomised trial. 24th International AIDS Conference, Montreal, 29 July − 2 August 2022. Abstract no OALBX0103, 2022.
    · extracted · source: references/10665-362227.sec-035.52.json
  54. Truong R, Tang V, Grennan T, Tan DHS. A systematic review of the impacts of oral tetracycline class antibiotics on antimicrobial resistance in normal human flora. JAC Antimicrob Resist. 2022; 15;4(1):dlac009.
    · extracted · source: references/10665-362227.sec-035.53.json
  55. Kohli M, Medland N, Fifer H, Saunders J. BASHH updated position statement on doxycycline as prophylaxis for sexually transmitted infections. Sex Transm Infect. 2022;98(3):235-236.
    · extracted · source: references/10665-362227.sec-035.54.json
  56. WHO preferred product characteristics for gonococcal vaccines. Geneva: World Health Organization; 2021 (https://www.who.int/publications/i/item/9789240039827, accessed 8 August 2022).
    · extracted · link · source: references/10665-362227.sec-035.55.json
  57. Ong JJ, Unemo M, Choong AL, Zhao V, Chow EP. Is the end of gonorrhoea in sight? Lancet Infect Dis. 2022:S1473-3099(22)00002-0. Epub ahead of print.
    · extracted · source: references/10665-362227.sec-035.56.json
  58. Ruiz García Y, Sohn WY, Seib KL, Taha MK, Vazquez JA, de Lemos APS et al. Looking beyond meningococcal B with the 4CMenB vaccine: the Neisseria effect. NPJ Vaccines. 2021 Oct;6(1):130.
    · extracted · source: references/10665-362227.sec-035.57.json
  59. Counselling for maternal and newborn health care: a handbook for building skills. Geneva: World Health Organization; 2013 (https://apps.who.int/iris/handle/10665/44016, accessed 29 August).
    · extracted · link · source: references/10665-362227.sec-035.58.json
  60. Consolidated guidelines on HIV, viral hepatitis and STI prevention, diagnosis, treatment and care for key populations. Geneva: World Health Organization; 2022 (https://www.who.int/publications/i/item/9789240052390, accessed 29 July 2022).
    · extracted · link · source: references/10665-362227.sec-035.59.json
  61. Schreck B, Victorri-Vigneau C, Guerlais M, Laforgue E, Grall-Bronnec M. Slam practice: a review of the literature. European Addiction Research. 2021;27(3):161–78.
    · extracted · source: references/10665-362227.sec-035.60.json
  62. Tomkins A, George R, Kliner M. Sexualised drug taking among men who have sex with men: a systematic review. Perspect Public Health. 2019;139(1):23–33.
    · extracted · source: references/10665-362227.sec-035.61.json
  63. Wang H, Zhang L, Zhou Y, Wang K, Zhang X, Wu J et al. The use of geosocial networking smartphone applications and the risk of sexually transmitted infections among men who have sex with men: a systematic review and meta-analysis. BMC Public Health. 2018;18(1):1178.
    · extracted · source: references/10665-362227.sec-035.62.json
  64. Morris BJ, Hankins CA, Banerjee J, Lumbers ER, Mindel A, Klausner JD et al. Does male circumcision reduce women’s risk of sexually transmitted infections, cervical cancer, and associated conditions? Front Public Health. 2019;7:4.
    · extracted · source: references/10665-362227.sec-035.63.json
  65. Grund JM, Bryant TS, Jackson I, Curran K, Bock N, Toledo C et al. Association between male circumcision and women’s biomedical health outcomes: a systematic review. Lancet Glob Health. 2017;5:e1113-e22.
    · extracted · source: references/10665-362227.sec-035.64.json
  66. Yuan T, Fitzpatrick T, Ko N-Y, Cai Y, Chen Y, Zhao J et al. Circumcision to prevent HIV and other sexually transmitted infections in men who have sex with men: a systematic review and meta-analysis of global data. Lancet Glob Health. 2019;7:e436-e47.
    · extracted · source: references/10665-362227.sec-035.65.json
  67. Responding to intimate partner violence and sexual violence against women: WHO clinical and policy guidelines. Geneva: World Health Organization; 2013 (https://apps.who.int/iris/bitstream/handle/10665/85240/9789241548595_eng.pdf, accessed 9 August 2022).
    · extracted · link · source: references/10665-362227.sec-035.66.json
  68. Caring for women subjected to violence: A WHO training curriculum for health care providers, revised edition. Geneva: World Health Organization; 2021 (https://www.who.int/publications/i/item/9789240039803, accessed 8 August 2022).
    · extracted · link · source: references/10665-362227.sec-035.67.json
  69. World Health Organization. WHO position paper on hepatitis A vaccines. Wkly Epidemiol Rec. 2012;87(28-29):261-76 (https://www.who.int/teams/immunization-vaccines-and-biologicals/policies/position-papers/hepatitis-a, accessed 5 August 2022).
    · extracted · link · source: references/10665-362227.sec-035.68.json
  70. World Health Organization. Hepatitis B vaccines: WHO position paper. Wkly Epidemiol Rec. 2017;27(92): 369-392 (https://apps.who.int/iris/bitstream/handle/10665/255841/WER9227.pdf?sequence=1, accessed 29 July 2022).
    · extracted · link · source: references/10665-362227.sec-035.69.json
  71. WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention. Geneva: World Health Organization; 2021 (https://www.who.int/publications-detail-redirect/9789240030824, accessed 8 August 2022).
    · extracted · link · source: references/10665-362227.sec-035.70.json
  72. Yakely AE, Avni-Singer L, Oliveira CR, Niccolai LM. Human papillomavirus vaccination and anogenital warts: a systematic review of impact and effectiveness in the United States. Sex Transm Dis. 2019;46(4):213-220.
    · extracted · source: references/10665-362227.sec-035.71.json
  73. Kennedy CE, Yeh PT, Li J, Gonsalves L, Narasimhan M. Lubricants for the promotion of sexual health and well-being: a systematic review. Sex Reprod Health Matters. 2022;29(3):2044198.
    · extracted · source: references/10665-362227.sec-035.72.json
  74. Laboratory diagnosis of sexually transmitted infections, including human immunodeficiency virus. Geneva: World Health Organization; 2013 (http://apps.who.int/iris/bitstream/10665/85343/1/9789241505840_eng.pdf?ua=1, accessed 29 July 2022).
    · extracted · link · source: references/10665-362227.sec-035.73.json
  75. Ong J et al. Testing frequency for sexually transmitted infections for users of HIV pre-exposure prophylaxis: a systematic review and meta-analysis. Unpublished.
    · extracted · source: references/10665-362227.sec-035.74.json
  76. WHO guideline on syphilis screening and treatment for pregnant women. Geneva: World Health Organization; 2017 (https://www.who.int/publications/i/item/9789241550093, accessed 29 July 2022).
    · extracted · link · source: references/10665-362227.sec-035.75.json
  77. Guidance on syphilis testing in Latin American and the Caribbean: improving uptake, interpretation and quality of testing in different clinical settings. Washington DC: Pan American Health Organization; 2015 (https://iris.paho.org/handle/10665.2/7706, accessed 29 July 2022).
    · extracted · link · source: references/10665-362227.sec-035.76.json
  78. Zhang Y, Goh SM, Mello MB, Baggaley R, Wi T, Johnson C et al. Improved rapid diagnostic tests to detect syphilis and yaws: a systematic review and meta-analysis. Available at (SRN: https://ssrn.com/abstract=4058234 or http://dx.doi.org/10.2139/ssrn.4058234, accessed 29 July 2022).
    · extracted · link · doi:10.2139/ssrn.4058234 · source: references/10665-362227.sec-035.77.json
  79. Eradication of yaws – A guide for programme managers. Geneva: World Health Organization; 2018 (https://www.who.int/publications/i/item/9789241512695, accessed 29 July 2022).
    · extracted · link · source: references/10665-362227.sec-035.78.json
  80. Verougstraete N, Verbeke V, De Canniere AS, Simons C, Padalko E, Coorevits L. To pool or not to pool? Screening of Chlamydia trachomatis and Neisseria gonorrhoeae in female sex workers: pooled versus single-site testing. Sex Transm Infect. 2020;96(6):417–421.
    · extracted · source: references/10665-362227.sec-035.79.json
  81. De Baetselier I, Osbak KK, Smet H, Kenyon CR, Crucitti T. Take three, test one: a cross-sectional study to evaluate the molecular detection of Chlamydia trachomatis and Neisseria gonorrhoeae in pooled pharyngeal, anorectal and urine samples versus single-site testing among men who have sex with men in Belgium. Acta Clin Belg. 2020;75(2):91–95.
    · extracted · source: references/10665-362227.sec-035.80.json
  82. Aboud L, Xu Y, Chow EPF, Wi T, Baggaley R, Mello MB et al. Diagnostic accuracy of pooling urine, anorectal, and oropharyngeal specimens for the detection of Chlamydia trachomatis and Neisseria gonorrhoeae: a systematic review and meta-analysis. BMC Med. 2021 Nov 25;19(1):285.
    · extracted · source: references/10665-362227.sec-035.81.json
  83. WHO Guidelines for the treatment of Chlamydia trachomatis. Geneva: World Health Organization; 2016 (https://www.who.int/publications-detail-redirect/978-92-4-154971-4, accessed 8 August 2022).
    · extracted · link · source: references/10665-362227.sec-035.82.json
  84. WHO Guidelines for the treatment of Neisseria gonorrhoeae. Geneva: World Health Organization; 2016 (https://www.who.int/publications-detail-redirect/9789241549691, accessed 8 August 2022).
    · extracted · link · source: references/10665-362227.sec-035.83.json
  85. WHO Guidelines for the management of symptomatic sexually transmitted infections. Geneva: World Health Organization; 2021 (https://www.who.int/publications/i/item/9789240024168, accessed 8 August 2022).
    · extracted · link · source: references/10665-362227.sec-035.84.json
  86. WHO Implementation tool for pre-exposure prophylaxis (PrEP) of HIV infection. Module 3: Counsellors. Geneva: World Health Organization; 2017 (https://apps.who.int/iris/handle/10665/258517, accessed 29 July 2022).
    · extracted · link · source: references/10665-362227.sec-035.85.json · held: library/10665-258517
  87. WHO Consolidated guidelines on HIV testing services. Geneva: World Health Organization; 2019 (https://www.who.int/publications-detail-redirect/978-92-4-155058-1, accessed 29 July 2022).
    · extracted · link · source: references/10665-362227.sec-035.86.json
  88. Torrone EA, Morrison CS, Chen PL, Kwok C, Francis SC, Hayes RJ et al. Prevalence of sexually transmitted infections and bacterial vaginosis among women in sub-Saharan Africa: An individual participant data meta-analysis of 18 HIV prevention studies. PLoS Med. 2018;15(2):e1002511.
    · extracted · source: references/10665-362227.sec-035.87.json
  89. Newton-Levinson A, Leichliter JS, Chandra-Mouli V. Sexually transmitted infection services for adolescents and youth in low- and middle-income countries: perceived and experienced barriers to accessing care. J Adolesc Health. 2016;59(1):7-16.
    · extracted · source: references/10665-362227.sec-035.88.json
  90. Iwuji CC, Martin CE, Pillay D, Shamu P, Nzenze S, Murire M et al. Preferences for the management of sexually transmitted infections in the South African health system: A discrete choice experiment. medRxiv. 2022. doi: 10.1101/2022.03.07.22271994.
    · extracted · doi:10.1101/2022.03.07.22271994 · source: references/10665-362227.sec-035.89.json
  91. Vaccines and immunization for monkeypox. Interim guidance. Geneva: World Health Organization; 2022 (https://apps.who.int/iris/rest/bitstreams/1461005/retrieve, accessed 30 August 2022).
    · extracted · link · source: references/10665-362227.sec-035.90.json
  92. Consolidated guidelines on HIV, viral hepatitis and STI prevention, diagnosis, treatment and care for key populations. Geneva: World Health Organization; 2022 (https://www.who.int/publications/i/item/9789240052390)
    · extracted · link · source: references/10665-362227.sec-036.1.json
  93. WHO Guidelines for the management of symptomatic sexually transmitted infections. Geneva: World Health Organization; 2021 (https://www.who.int/publications/i/item/9789240024168)
    · extracted · link · source: references/10665-362227.sec-036.2.json
  94. Self-collection of samples for sexually transmitted infections (STIs). Geneva: World Health Organization; 2020 (https://www.who.int/publications/i/item/WHO-SRH-20.10)
    · extracted · link · source: references/10665-362227.sec-036.3.json
  95. WHO guideline on syphilis screening and treatment for pregnant women. Geneva: World Health Organization; 2017 (https://www.who.int/publications/i/item/9789241550093)
    · extracted · link · source: references/10665-362227.sec-036.4.json
  96. WHO Guidelines for the treatment of Chlamydia trachomatis. Geneva: World Health Organization ; 2016 (https://www.who.int/publications-detail-redirect/978-92-4-154971-4; accessed 8 August 2022).
    · extracted · link · source: references/10665-362227.sec-036.5.json
  97. WHO guidelines for the treatment of genital herpes simplex virus. Geneva: World Health Organization; 2016 (https://www.who.int/publications/i/item/978924154987, accessed 29 July 2022).
    · extracted · link · source: references/10665-362227.sec-036.6.json
  98. WHO Guidelines for the treatment of Neisseria gonorrhoeae. Geneva: World Health Organization; 2016 (https://www.who.int/publications-detail-redirect/9789241549691, accessed 8 August 2022).
    · extracted · link · source: references/10665-362227.sec-036.7.json
  99. WHO Guidelines for the treatment of Treponema pallidum (syphilis). Geneva: World Health Organization; 2016 (https://www.who.int/publications/i/item/9789241549714, accessed 29 July 22).
    · extracted · link · source: references/10665-362227.sec-036.8.json
  100. WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention. Geneva: World Health Organization; 2021 (https://www.who.int/publications-detail-redirect/9789240030824, accessed 8 August 2022).
    · extracted · link · source: references/10665-362227.sec-036.9.json
  101. Updated recommendations on simplified service delivery and diagnostics for hepatitis C infection. Geneva: World Health Organization; 2022 (https://www.who.int/publications/i/item/9789240052697, accessed 8 August 2022)
    · extracted · link · source: references/10665-362227.sec-036.10.json
  102. Updated recommendations on treatment of adolescents and children with chronic HCV infection. Geneva: World Health Organization; 2022 (https://www.who.int/publications/i/item/9789240052710, accessed 29 July 2022).
    · extracted · link · source: references/10665-362227.sec-036.11.json
  103. Recommendations and guidance on hepatitis C virus self-testing. Geneva: World Health Organization; 2021 (https://www.who.int/publications/i/item/9789240031128, accessed 29 July 2022).
    · extracted · link · source: references/10665-362227.sec-036.12.json
  104. Guidelines for the care and treatment of persons diagnosed with chronic hepatitis C virus infection. Geneva: World Health Organization; 2018 (https://www.who.int/publications/i/item/9789241550345, accessed 29 July 2022).
    · extracted · link · source: references/10665-362227.sec-036.13.json
  105. Guidelines on hepatitis B and C testing. Geneva: World Health Organization; 2017 (https://www.who.int/publications/i/item/9789241549981, accessed 29 July 2022).
    · extracted · link · source: references/10665-362227.sec-036.14.json
  106. Guidelines for the prevention, care and treatment of persons with chronic hepatitis B infection. Geneva: World Health Organization; 2015 (https://www.who.int/publications/i/item/9789241549059, accessed 29 July 2022).
    · extracted · link · source: references/10665-362227.sec-036.15.json
  107. Consolidated guidelines on person-centred HIV strategic information: strengthening routine data for impact. Geneva: World Health Organization; 2022 (https://www.who.int/publications/i/item/9789240055315, accessed 8 August 2022).
    · extracted · link · source: references/10665-362227.sec-036.16.json
  108. Consolidated guidelines on person-centred HIV strategic information: strengthening routine data for impact. Geneva: World Health Organization; 2022 (https://www.who.int/publications/i/item/9789240055315, accessed 8 August 2022).
    · extracted · link · source: references/10665-362227.sec-038.1.json
  109. WHO Guidelines for the management of symptomatic sexually transmitted infections. Geneva: World Health Organization; 2021 (https://www.who.int/publications/i/item/9789240024168, accessed 8 August 2022).
    · extracted · link · source: references/10665-362227.sec-038.2.json
  110. WHO guidelines for the treatment of genital herpes simplex virus. Geneva: World Health Organization; 2016 (https://www.who.int/publications/i/item/978924154987, accessed 29 July 2022).
    · extracted · link · source: references/10665-362227.sec-039.1.json
  111. Guidelines for the prevention, care and treatment of persons with chronic hepatitis B infection. Geneva: World Health Organization; 2015 (https://www.who.int/publications/i/item/9789241549059, accessed 29 July 2022).
    · extracted · link · source: references/10665-362227.sec-039.2.json
  112. Self-collection of samples for sexually transmitted infections (STIs). Geneva: World Health Organization; 2020 (https://www.who.int/publications/i/item/WHO-SRH-20.10, accessed 8 August 2022).
    · extracted · link · source: references/10665-362227.sec-040.1.json
  113. Laboratory diagnosis of sexually transmitted infections, including human immunodeficiency virus. Geneva: World Health Organization; 2013 (http://apps.who.int/iris/bitstream/10665/85343/1/9789241505840_eng.pdf?ua=1, accessed 29 July 2022).
    · extracted · link · source: references/10665-362227.sec-040.2.json
  114. WHO Guidelines for the treatment of Chlamydia trachomatis. Geneva: World Health Organization; 2016 (https://www.who.int/publications-detail-redirect/978-92-4-154971-4; accessed 8 August 2022).
    · extracted · link · source: references/10665-362227.sec-040.3.json
  115. Consolidated guidelines on HIV, viral hepatitis and STI prevention, diagnosis, treatment and care for key populations. Geneva: World Health Organization; 2022 (https://www.who.int/publications/i/item/9789240052390, accessed 29 July 2022).
    · extracted · link · source: references/10665-362227.sec-040.4.json
  116. WHO guidelines for the treatment of genital herpes simplex virus. Geneva: World Health Organization; 2016 (https://www.who.int/publications/i/item/978924154987, accessed 29 July 2022).
    · extracted · link · source: references/10665-362227.sec-040.5.json
  117. Workowski KA, Bachmann LH, Chan PA, Johnston CM, Muzny CA, Park I, et al. Sexually transmitted infections treatment guidelines, 2021. MMWR Recomm Rep. 2021;70(4):1-187.
    · extracted · source: references/10665-362227.sec-040.6.json
  118. Guidelines on hepatitis B and C testing. Geneva: World Health Organization; 2017 (https://www.who.int/publications/i/item/9789241549981, accessed 29 July 2022).
    · extracted · link · source: references/10665-362227.sec-040.7.json
  119. Guidelines for the prevention, care and treatment of persons with chronic hepatitis B infection. Geneva: World Health Organization; 2015 (https://www.who.int/publications/i/item/9789241549059, accessed 29 July 2022).
    · extracted · link · source: references/10665-362227.sec-040.8.json
  120. Updated recommendations on simplified service delivery and diagnostics for hepatitis C infection. Geneva: World Health Organization; 2022 (https://www.who.int/publications/i/item/9789240052697, accessed 29 July 2022).
    · extracted · link · source: references/10665-362227.sec-040.9.json
  121. Recommendations and guidance on hepatitis C virus self-testing. Geneva: World Health Organization; 2021 (https://www.who.int/publications/i/item/9789240031128, accessed 29 July 2022).
    · extracted · link · source: references/10665-362227.sec-040.10.json
  122. Updated recommendations on treatment of adolescents and children with chronic HCV infection. Geneva: World Health Organization; 2022 (https://www.who.int/publications/i/item/9789240052710, accessed 29 July 2022).
    · extracted · link · source: references/10665-362227.sec-040.11.json
  123. Guidelines for the care and treatment of persons diagnosed with chronic hepatitis C virus infection. Geneva: World Health Organization; 2018 (https://www.who.int/publications/i/item/9789241550345, accessed 29 July 2022).
    · extracted · link · source: references/10665-362227.sec-040.12.json
  124. WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention. Geneva: World Health Organization; 2021 (https://www.who.int/publications-detail-redirect/9789240030824, accessed 8 August 2022).
    · extracted · link · source: references/10665-362227.sec-040.13.json
  125. WHO Guidelines for the treatment of Neisseria gonorrhoeae. Geneva: World Health Organization; 2016 (https://www.who.int/publications-detail-redirect/9789241549691, accessed 8 August 2022).
    · extracted · link · source: references/10665-362227.sec-040.14.json
  126. WHO Guidelines for the treatment of Treponema pallidum (syphilis). Geneva: World Health Organization; 2016 (https://www.who.int/publications/i/item/9789241549714, accessed 29 July 22).
    · extracted · link · source: references/10665-362227.sec-040.15.json
  127. WHO Guidelines for the management of symptomatic sexually transmitted infections. Geneva: World Health Organization; 2021 (https://www.who.int/publications/i/item/9789240024168, accessed 8 August 2022). For more information, contact: World Health Organization Global HIV, Hepatitis and STIs Programmes 20, avenue Appia 1211 Geneva 27 Switzerland E-mail: hiv-aids@who.int www.who.int/hiv
    · extracted · link · source: references/10665-362227.sec-040.16.json